Skip to main content
Premium Trial:

Request an Annual Quote

Kathryn Tunstall, Robert Nelsen, Regis McKenna, David Singer, Luke Evnin, Robert Hennessey, Steven Rauscher, Norbert Riedel, Vernon Loucks Jr., William Rutter, David Stone, Elizabeth Hutt, Anne Kopf-Sill, John Todd


Kathryn Tunstall and Edgar Cummins have been elected to the board of directors of Caliper Life Sciences, the company said last week. The new members fill vacancies created by retirements.

Tunstall replaces Robert Nelsen, managing director at Arch Venture Partners, while Cummins replaces Regis McKenna, a marketing guru.

The company said in a statement that the appointments are part of a series of organizational changes designed to “enhance and support Caliper’s increased focus on the life-sciences industry.”

Tunstall previously was president and CEO of Conceptus (1993-2000). She is on the board at Conceptus, Solarant Medical, and Fair Advantage. Previously, Tunstall was an executive with American Hospital Supply and Baxter International. Cummins, a member of the board of directors of Ocular Sciences, previously was CFO for Allergan.

David Singer, founding CEO of Genesoft and Affymetrix, will serve as chairman of the new board of directors for Genome Therapeutics, which completed a merger with Genesoft Pharmaceuticals last week. The new board includes: Luke Evnin, managing director of MPM Asset Management; Robert Hennessey, former chairman and CEO of Baxter International; Steven Rauscher, president and CEO of Genome Therapeutics; William Reardon, former life sciences industry practice partner at PricewaterhouseCoopers; Norbert Riedel, chief scientific officer at Baxter International; Vernon Loucks Jr., former chairman and CEO of Baxter International, CEO of Segway, and a board member of Affymetrix; William Rutter, professor emeritus at the University of California, San Francisco and founder of Chiron; and David Stone, managing director of Flagship Ventures.

Elizabeth Hutt, Anne Kopf-Sill, and John Todd join Nugen Technologies of San Carlos, the company said last week. Hutt, previously vice president of sales and service for Tripos and a former Affymetrix sales manager, will serve in that position at Nugen; Kopf-Sill, previously vice president for new products at Caliper Technologies, will become vice president of product development. Todd will serve as vice president of marketing.


The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.